AJR
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yamabe, Y.
Right arrow Articles by Sekiguchi, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yamabe, Y.
Right arrow Articles by Sekiguchi, R.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Hotlight (NEW!)
Right arrow
What's Hotlight?

Tumor Staging of Advanced Esophageal Cancer: Combination of Double-Contrast Esophagography and Contrast-Enhanced CT

Yuichiro Yamabe1, Yoshifumi Kuroki1, Tsutomu Ishikawa2, Kunihisa Miyakawa3, Seiko Kuroki4 and Ryuzo Sekiguchi1

1 Department of Diagnostic Imaging, Tochigi Cancer Center, 4-9-13 Yonan, Utsunomiya-shi, Tochigi 3200834, Japan.
2 Department of Radiology, Dokkyo Medical University Hospital, Shimotsuga-gun, Tochigi, Japan.
3 Nagano PET Imaging and Diagnostic Center, Magano-shi, Japan.
4 National Cancer Center, Research Center for Cancer Prevention and Screening, Cancer Screening Division, Tokyo, Japan.


Figure 1
View larger version (89K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 1A 78-year-old man with type 2 esophageal cancer located in medial thoracic esophagus. Tumor was 105 mm; survival period was 2,694 days. Transaxial contrast-enhanced CT scan through level of left mainstem bronchus shows flattening of posterior wall. Diagnosis using CT alone was T4 based on invasion of bronchus.

 

Figure 2
View larger version (54K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 1B 78-year-old man with type 2 esophageal cancer located in medial thoracic esophagus. Tumor was 105 mm; survival period was 2,694 days. Frontal double-contrast esophagogram shows tumor and deepest ulcer are on right posterior wall on opposite side of left main bronchus. These findings led to diagnosis of T3 using CT and double-contrast esophagography. Postoperative pathology revealed no invasion of left main bronchus.

 

Figure 3
View larger version (138K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 2A 55-year-old man with type 2 esophageal cancer located in upper thoracic esophagus. Tumor was 80 mm; survival period was 320 days. Transaxial contrast-enhanced CT scan through level of primary bronchus shows convex inward deformity of posterior wall. Diagnosis of T4 was made using CT alone based on invasion of bronchus.

 

Figure 4
View larger version (58K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 2B 55-year-old man with type 2 esophageal cancer located in upper thoracic esophagus. Tumor was 80 mm; survival period was 320 days. Frontal double-contrast esophagogram shows tumor and deepest ulcer are on left posterior wall on opposite side of primary main bronchus, leading to diagnosis of T3 using CT and double-contrast esophagography. Postoperative pathology revealed no invasion of primary main bronchus.

 

Figure 5
View larger version (21K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 3 Survival curve of pT3 and pT4 cases. For patients with pT3 disease, 3-year survival rate was 44% and median survival time was 792 days. For patients with pT4 disease, 3-year survival rate was 19% and median survival time was 256 days. Significant difference was observed between two stages (p = 0.001).

 

Figure 6
View larger version (22K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 4 Survival curve of T3 and T4 cases diagnosed using CT alone. For patients with T3 disease, 3-year survival rate was 42% and median survival time was 644 days. For patients with T4 disease, 3-year survival rate was 26% and median survival time was 367 days. No significant difference was observed between two stages (p = 0.055).

 

Figure 7
View larger version (24K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 5 Survival curve of T3 and T4 cases diagnosed using both CT and double-contrast esophagography. For patients with T3 disease, 3-year survival rate was 42% and median survival time was 783 days. For patients with T4 disease, 3-year survival rate was 21% and median survival time was 263 days. Significant difference was observed (p = 0.024).

 

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by the American Roentgen Ray Society.